IMRN

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Immuron Ltd ADR

NASDAQ | IMRN

2.15

USD

$0.00

(

0.00%

)

At Close (As of Oct 24, 2025)

$14.61M

Market Cap

-

P/E Ratio

-0.59

EPS

$2.48

52 Week High

$1.50

52 Week Low

HEALTHCARE

Sector

IMRN Chart

Recent Chart
Price Action

IMRN Technicals

Tags:

IMRN Earnings

Yearly Income Statement (As of Jun 30, 2025)

Field Value (AUD)
Gross Profit $4.8M
Total Revenue $7.3M
Cost Of Revenue $2.5M
Costof Goods And Services Sold $2.5M
Operating Income -$5.3M
Selling General And Administrative $4.5M
Research And Development $3.6M
Operating Expenses $10M
Investment Income Net -
Net Interest Income $129K
Interest Income $136K
Interest Expense $7.3K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $50K
Income Before Tax -$5.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$5.2M
Comprehensive Income Net Of Tax -
Ebit -$5.4M
Ebitda -$5.3M
Net Income -$5.2M

Revenue & Profitability

Earnings Performance

IMRN Financials

yearly Balance Sheet (As of Jun 30, 2025)

Field Value (AUD)
Total Assets $10M
Total Current Assets $10M
Cash And Cash Equivalents At Carrying Value $2.8M
Cash And Short Term Investments $2.8M
Inventory $1.8M
Current Net Receivables $791K
Total Non Current Assets $115K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $3M
Other Current Assets $1.6M
Other Non Current Assets -
Total Liabilities $2.1M
Total Current Liabilities $2M
Current Accounts Payable $1M
Deferred Revenue -
Current Debt -
Short Term Debt $45K
Total Non Current Liabilities $95K
Capital Lease Obligations $72K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $117K
Other Current Liabilities $914K
Other Non Current Liabilities -
Total Shareholder Equity $8.1M
Treasury Stock -
Retained Earnings -$82M
Common Stock $89M
Common Stock Shares Outstanding $5.8M

yearly Cash Flow (As of Jun 30, 2025)

Field Value (AUD)
Operating Cashflow -$6.1M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $50K
Capital Expenditures $0
Change In Receivables -
Change In Inventory $481K
Profit Loss -
Cashflow From Investment -$2.9M
Cashflow From Financing $200K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $0
Dividend Payout Common Stock $0
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$5.2M

yearly Income Statement (As of Jun 30, 2025)

Field Value (AUD)
Gross Profit $4.8M
Total Revenue $7.3M
Cost Of Revenue $2.5M
Costof Goods And Services Sold $2.5M
Operating Income -$5.3M
Selling General And Administrative $4.5M
Research And Development $3.6M
Operating Expenses $10M
Investment Income Net -
Net Interest Income $129K
Interest Income $136K
Interest Expense $7.3K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $50K
Income Before Tax -$5.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$5.2M
Comprehensive Income Net Of Tax -
Ebit -$5.4M
Ebitda -$5.3M
Net Income -$5.2M

IMRN News

IMRN Profile

Immuron Ltd ADR Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Immuron Ltd ADR is a biopharmaceutical company dedicated to developing innovative oral immunotherapy solutions harnessing polyclonal antibodies to treat infectious and immunomodulated diseases. Operating globally with research and development activities based in Australia and the United States, Immuron is headquartered in Carlton, Australia. The company is focused on utilizing its proprietary technologies to improve patient outcomes while strategically expanding its product pipeline, positioning itself competitively within the biopharmaceutical sector.

WGRX
+247.48%
$1.40
YYAI
-15.73%
$0.07
BYND
+8.08%
$3.06
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
VIVK
+25.55%
$0.32
YDKG
-19.77%
$0.05
QBTS
+13.81%
$31.06
BITF
+5.71%
$4.16
WTO
-7.04%
$0.06
INTC
+3.35%
$39.44
AREB
+75.34%
$3.77
NEUP
+52.46%
$6.17
AXDX
-61.36%
$0.03
ADTX
+2.70%
$0.30
VZ
-3.51%
$38.40
BURU
+3.07%
$0.35
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
QLGN
+44.75%
$5.11
SCNX
-35.00%
$1.69
GPUS
-0.28%
$0.38
TSLA
-2.28%
$438.71
SRM
+53.27%
$10.30
AMZN
+1.44%
$221.09
AMD
+7.54%
$252.72
AAL
+6.45%
$13.59
CUTR
-10.19%
$0.09
DVLT
+15.10%
$2.58
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
ETWO
0.00%
$3.30
RIG
+4.11%
$4.05
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
KDLY
+10.41%
$0.79
BMNR
+2.41%
$49.19
NOK
+0.32%
$6.18
F
+7.20%
$13.22
RANI
-13.45%
$2.09
OPI
-16.97%
$0.20
BULL
+2.30%
$11.08
KLG
-9.05%
$13.35
RGTI
+7.39%
$42.52
GRYP
-10.38%
$1.38
CAN
+4.26%
$1.83
MODV
-25.22%
$0.43
LXEH
+24.60%
$0.56
OKLO
+3.81%
$124.70
ASST
+10.78%
$0.86
IBM
-0.87%
$285.00
EOSE
-4.64%
$14.36
NRXS
-7.72%
$3.52
AMC
-1.46%
$2.69
NBIS
+7.64%
$106.16
LAES
+2.70%
$5.87
PLTR
+2.45%
$184.91
GNTA
+86.06%
$6.01
SAND
-6.04%
$12.12
SHOT
-74.37%
$0.39
IONZ
-9.04%
$3.62
ZAPP
-46.30%
$0.15
CIFR
+12.19%
$19.36
PLUG
+3.77%
$2.98
HOOD
+2.75%
$138.02
KDP
+0.58%
$27.55
NGD
+0.62%
$6.46
NUAI
+18.73%
$4.69
BAC
+1.63%
$52.60
DNN
+1.09%
$2.76
WMT
-0.26%
$106.86
NIO
-0.21%
$6.87
IAG
-0.08%
$12.04
RXRX
+0.61%
$5.76
NEHC
+4.22%
$3.95
QS
+2.69%
$15.05
ADAP
+0.85%
$0.07
BREA
+36.64%
$11.41
RR
+5.53%
$5.72
ABEV
+0.67%
$2.22
SMR
+3.72%
$38.95
MSAI
-46.40%
$0.72
SOC
+18.61%
$14.02
ACHR
+3.22%
$11.26
BBD
-0.14%
$3.34
TLRY
+0.76%
$1.49
TGB
+5.15%
$4.08
RVPH
+7.10%
$0.60
ADVM
+3.82%
$4.34
MU
+4.65%
$216.33
IMG
+3.79%
$0.23
DEFT
-1.47%
$2.00
UUUU
+0.23%
$21.31
ONDS
+9.27%
$7.71
CAG
-1.65%
$18.47
T
+0.52%
$24.74
HTZ
+4.84%
$5.19
BP
+1.98%
$35.00
LUMN
+5.71%
$8.23
SOFI
+5.09%
$29.51
WGRX
+247.48%
$1.40
YYAI
-15.73%
$0.07
BYND
+8.08%
$3.06
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
VIVK
+25.55%
$0.32
YDKG
-19.77%
$0.05
QBTS
+13.81%
$31.06
BITF
+5.71%
$4.16
WTO
-7.04%
$0.06
INTC
+3.35%
$39.44
AREB
+75.34%
$3.77
NEUP
+52.46%
$6.17
AXDX
-61.36%
$0.03
ADTX
+2.70%
$0.30
VZ
-3.51%
$38.40
BURU
+3.07%
$0.35
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
QLGN
+44.75%
$5.11
SCNX
-35.00%
$1.69
GPUS
-0.28%
$0.38
TSLA
-2.28%
$438.71
SRM
+53.27%
$10.30
AMZN
+1.44%
$221.09
AMD
+7.54%
$252.72
AAL
+6.45%
$13.59
CUTR
-10.19%
$0.09
DVLT
+15.10%
$2.58
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
ETWO
0.00%
$3.30
RIG
+4.11%
$4.05
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
KDLY
+10.41%
$0.79
BMNR
+2.41%
$49.19
NOK
+0.32%
$6.18
F
+7.20%
$13.22
RANI
-13.45%
$2.09
OPI
-16.97%
$0.20
BULL
+2.30%
$11.08
KLG
-9.05%
$13.35
RGTI
+7.39%
$42.52
GRYP
-10.38%
$1.38
CAN
+4.26%
$1.83
MODV
-25.22%
$0.43
LXEH
+24.60%
$0.56
OKLO
+3.81%
$124.70
ASST
+10.78%
$0.86
IBM
-0.87%
$285.00
EOSE
-4.64%
$14.36
NRXS
-7.72%
$3.52
AMC
-1.46%
$2.69
NBIS
+7.64%
$106.16
LAES
+2.70%
$5.87
PLTR
+2.45%
$184.91
GNTA
+86.06%
$6.01
SAND
-6.04%
$12.12
SHOT
-74.37%
$0.39
IONZ
-9.04%
$3.62
ZAPP
-46.30%
$0.15
CIFR
+12.19%
$19.36
PLUG
+3.77%
$2.98
HOOD
+2.75%
$138.02
KDP
+0.58%
$27.55
NGD
+0.62%
$6.46
NUAI
+18.73%
$4.69
BAC
+1.63%
$52.60
DNN
+1.09%
$2.76
WMT
-0.26%
$106.86
NIO
-0.21%
$6.87
IAG
-0.08%
$12.04
RXRX
+0.61%
$5.76
NEHC
+4.22%
$3.95
QS
+2.69%
$15.05
ADAP
+0.85%
$0.07
BREA
+36.64%
$11.41
RR
+5.53%
$5.72
ABEV
+0.67%
$2.22
SMR
+3.72%
$38.95
MSAI
-46.40%
$0.72
SOC
+18.61%
$14.02
ACHR
+3.22%
$11.26
BBD
-0.14%
$3.34
TLRY
+0.76%
$1.49
TGB
+5.15%
$4.08
RVPH
+7.10%
$0.60
ADVM
+3.82%
$4.34
MU
+4.65%
$216.33
IMG
+3.79%
$0.23
DEFT
-1.47%
$2.00
UUUU
+0.23%
$21.31
ONDS
+9.27%
$7.71
CAG
-1.65%
$18.47
T
+0.52%
$24.74
HTZ
+4.84%
$5.19
BP
+1.98%
$35.00
LUMN
+5.71%
$8.23
SOFI
+5.09%
$29.51
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.